ADVANCED CELL THERAPY LABORATORY

About us

Advanced cell therapies for clinical use, with quality control and traceability for every lot.

IPRESS Code 00027120

Peru's first advanced cell therapy laboratory

ABOUT US

V&C BIOTEC

We are the first biotechnology company in Peru to develop advanced cell therapies for clinical use, following European Union Good Manufacturing Practice guidelines. To that end, we have built a research platform grounded in the scientific and technological training of our team.

We have specialized equipment and an infrastructure designed exclusively for the clinical-scale manufacturing of advanced cell therapies and for research into new therapies that can reach more patients.

IPRESS Registration No. 00027120

OUR VALUES

The principles that guide
our laboratory

CREATIVITY

We foster a work environment where our entire team develops their creativity, innovates and looks for new solutions to existing problems.

PASSION FOR OUR WORK

We are committed to achieving the highest levels of quality in everything we do, working with dedication to serve our internal and external clients every day.

RESPECT FOR PEOPLE

We respect the dignity of every person and promote a culture where ideas are expressed freely, regardless of hierarchical role within the company.

SOCIAL RESPONSIBILITY

We carry out our work with particular care for the natural environment, in order to serve the communities where we live and work.

EXCELENCE

We strive for excellence in everything we think, say and do.

TEAM WORK

We seek to build and maintain productive relationships in which the exchange of experience and knowledge allows us to create greater value across our teams, sites and business lines. Our business practices are guided by the highest ethical standards of truthfulness, integrity, responsibility and transparency.

RESEARCH

Research Team

For more information, contact our team leader Marco Cabello Napuri at

biologo@vcbiotec.com

The "Advanced Cell Therapy and Tissue Engineering" Research Group at V&C Biotec is led by Marco Cabello Napuri, MSc. The group applies tissue engineering techniques to repair and regenerate damaged tissue, and investigates advanced cell therapies in hemato-oncology with the aim of developing more effective treatments.

This work seeks to expand the therapeutic options available in Peru while advancing biotechnology in the country, benefiting public health and contributing to local scientific and technological development.